Tyrosine Kinase/Adaptors
Tyrosine kinase and adaptor inhibitors are compounds that target tyrosine kinases and their associated adaptor proteins, which play pivotal roles in cell signaling, growth, and differentiation. These inhibitors are essential tools in cancer research, as many tyrosine kinases are involved in the signaling pathways that drive tumor growth and metastasis. By inhibiting tyrosine kinases, these compounds can block critical signaling cascades, offering potential therapeutic strategies for various cancers and other diseases involving abnormal cell signaling. At CymitQuimica, we provide a comprehensive range of high-quality tyrosine kinase and adaptor inhibitors to support your research in oncology, molecular biology, and targeted therapy development.
Read more
Subcategories of "Tyrosine Kinase/Adaptors"
ALK
CSF-1R
EGFR
Ephrin Receptor
FLT
Fibroblast Growth Factor Receptor (FGFR)
HER
Hck
IGF-1R
PDGFR
PYK2
Src
TAM Receptor
Tie-2
Trk receptor
Tyrosine Kinases
VEGFR
c-Fms
c-Kit
c-Met/HGFR
c-RET
Show 13 more subcategories
Products of "Tyrosine Kinase/Adaptors"
DT-2 acetate
DT-2 acetate, a selective cGMP-dependent protein kinase (PKG) inhibitor, is a mouse monoclonal antibody targeting …
Formula:
C124H227N53O25
Purity:
99.80%
Color and Shape:
Liquid
Molecular weight:
2860.47
Ref: TM-T82525L
| 1mg | 95.00 € | ||
| 5mg | 225.00 € | ||
| 10mg | 334.00 € | ||
| 25mg | 563.00 € | ||
| 50mg | 801.00 € |
Estimated delivery in United States, on Monday 2 Dec 2024
FGFR1 inhibitor-8
FGFR1 inhibitor-8 (Compound 9), an FGFR1 inhibitor with an IC50 of 0.5 nM, binds to …
Formula:
C26H18ClNO5
Purity:
98%
Color and Shape:
Liquid
Molecular weight:
459.88
Ref: TM-T78831
| 5mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Monday 2 Dec 2024
EGFR mutant-IN-1
EGFR mutant-in-1, a 5-methylpyrimidopyridone, selectively inhibits EGFRL858R/T790M/C797S mutants with an IC50 of 27.5 nM, lessening …
Formula:
C34H39ClFN7O2
Purity:
98%
Color and Shape:
Solid
Molecular weight:
632.17
Ref: TM-T11164
| 100mg | To inquire | ||
| 500mg | To inquire |
Estimated delivery in United States, on Monday 2 Dec 2024
Duligotuzumab
CAS:1314238-96-4
Duligotuzumab (MEHD-7945A; RG 7597) is a humanized IgG-κ monoclonal antibody targeting Her3 (ErbB3) [1].
Purity:
98%
Color and Shape:
Liquid
Ref: TM-T80604
| 1mg | To inquire | ||
| 5mg | To inquire |
Estimated delivery in United States, on Monday 2 Dec 2024
EGFR-IN-81
EGFR-IN-81 (Compound 10i), an EGFR inhibitor, demonstrates potent activity by inhibiting EGFR WT and the …
Formula:
C28H24F3N5O4
Purity:
98%
Color and Shape:
Liquid
Molecular weight:
551.52
Ref: TM-T79327
| 5mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Monday 2 Dec 2024
hCA/VEGFR-2-IN-3
hCA/VEGFR-2-IN-3 (compound 8j) is an indolinonylbenzenesulfonamide with potential as a dual inhibitor of cancer-associated hCA …
Formula:
C24H28N6O6S
Purity:
98%
Color and Shape:
Liquid
Molecular weight:
528.58
Ref: TM-T79588
| 5mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Monday 2 Dec 2024
Vomifoliol
CAS:23526-45-6
Vomifoliol, precursor to dehydrovomifoliol and anti-proliferative for lung cancer, is made from ABA metabolism.
Formula:
C13H20O3
Purity:
98%
Color and Shape:
Solid
Molecular weight:
224.3
Ref: TM-TN5250
| 5mg | 1,217.00 € | ||
| 1mL*10mM (DMSO) | To inquire |
Estimated delivery in United States, on Monday 2 Dec 2024
hCA/VEGFR-2-IN-4
hCA/VEGFR-2-IN-4 (compound 15b), an indolinylbenzenesulfonamide, serves as a potential dual inhibitor targeting cancer-related human carbonic …
Formula:
C22H23FN6O5S
Purity:
98%
Color and Shape:
Liquid
Molecular weight:
502.52
Ref: TM-T79591
| 5mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Monday 2 Dec 2024
Cisapride hydrate
CAS:260779-88-2
Cisapride acts directly as a selective agonist of serotonin 5-HT4 receptor with IC50 value of …
Formula:
C23H31ClFN3O5
Purity:
98%
Color and Shape:
Solid
Molecular weight:
483.97
Ref: TM-T22296
| 500mg | 552.00 € |
Estimated delivery in United States, on Monday 2 Dec 2024
EGFR-IN-86
EGFR-IN-86 (compound 4i), an EGFR inhibitor (IC50: 1.5 nM), demonstrates potent activity against glioblastoma by …
Formula:
C20H21N7O2S
Purity:
98%
Color and Shape:
Liquid
Molecular weight:
423.49
Ref: TM-T78862
| 5mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Monday 2 Dec 2024
EGFR-IN-79
EGFR-IN-79 (compound 21), an EGFR inhibitor, exhibits antitumor activity through ROS-independent apoptosis and EGFR/AKT/mTOR-mediated autophagy.
Formula:
C23H16ClN3O3
Purity:
98%
Color and Shape:
Liquid
Molecular weight:
417.84
Ref: TM-T79293
| 5mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Monday 2 Dec 2024
FGFR1 inhibitor 7
FGFR1 Inhibitor 7 (compound 5), a potent FGFR1 tyrosine kinase inhibitor, exhibits an IC50 of …
Formula:
C25H16ClNO4
Purity:
98%
Color and Shape:
Liquid
Molecular weight:
429.85
Ref: TM-T78830
| 5mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Monday 2 Dec 2024
EGFR/BRAFV600E-IN-3
EGFR/BRAFV600E-IN-3 is an inhibitor targeting EGFR, BRAFV600E, and EGFRT790M with IC50 values of 57 nM, …
Formula:
C25H18N4O3
Purity:
98%
Color and Shape:
Liquid
Molecular weight:
422.44
Ref: TM-T78850
| 5mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Monday 2 Dec 2024
Gimsilumab
CAS:1648796-29-5
Gimsilumab (MORAb-022) is an anti-c-Fms humanized monoclonal antibody for the study of inflammation and hypoxemia …
Purity:
99.49% (SEC-HPLC) - 99.49% (SEC-HPLC)
Color and Shape:
Liquid
Ref: TM-T77025
| 1mg | 162.00 € | ||
| 5mg | 391.00 € | ||
| 10mg | 576.00 € | ||
| 25mg | 922.00 € |
Estimated delivery in United States, on Monday 2 Dec 2024
Motesanib Diphosphate
CAS:857876-30-3
Motesanib Diphosphate (AMG 706) is the orally bioavailable diphosphate salt of a multiple-receptor tyrosine kinase …
Formula:
C22H23N5O·2H3PO4
Purity:
99.76%
Color and Shape:
Solid
Molecular weight:
569.44
Ref: TM-T2288L
| 5mg | 42.00 € | ||
| 10mg | 56.00 € | ||
| 25mg | 94.00 € | ||
| 50mg | 166.00 € | ||
| 100mg | 276.00 € | ||
| 500mg | 677.00 € | ||
| 1mL*10mM (DMSO) | 59.00 € |
Estimated delivery in United States, on Monday 2 Dec 2024
SJF 1521
CAS:2230821-40-4
SJF 1521 is an EGFR degrader belonging to the PROTAC class that selectively degrades EGFR …
Formula:
C57H61ClFN7O9S
Purity:
99.20%
Color and Shape:
Liquid
Molecular weight:
1074.65
Ref: TM-T36244
| 1mg | 571.00 € |
Estimated delivery in United States, on Monday 2 Dec 2024
Becotatug
CAS:2648260-93-7
Becotatug (JMT-101) is an IgG1 antibody that targets EGFR and can be conjugated to Afatinib …
Purity:
98%
Color and Shape:
Liquid
Ref: TM-T80574
| 1mg | To inquire | ||
| 5mg | To inquire |
Estimated delivery in United States, on Monday 2 Dec 2024
BMS-599626 2HCL(714971-09-2 Free base)
CAS:1781932-33-9
BMS-599626 2HCL (AC480 2HCl) is a BMS-599626 derivative.
Formula:
C27H29Cl2FN8O3
Purity:
98%
Color and Shape:
Soild
Molecular weight:
603.47
Ref: TM-T2610L
| 1mg | 93.00 € | ||
| 5mg | 148.00 € | ||
| 10mg | 278.00 € | ||
| 25mg | 477.00 € | ||
| 50mg | 690.00 € | ||
| 100mg | 979.00 € | ||
| 1mL*10mM (DMSO) | 330.00 € |
Estimated delivery in United States, on Monday 2 Dec 2024
S6K2-IN-1
S6K2-IN-1 (Compound 2) is an inhibitor of S6K2 with an IC50 of 22 nM and …
Formula:
C24H23ClF3N9O2
Purity:
98%
Color and Shape:
Liquid
Molecular weight:
561.95
Ref: TM-T79871
| 5mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Monday 2 Dec 2024
Enapotamab
CAS:1912423-61-0
Enapotamab is an AXL/UFO-related antibody that can be used to synthesize antibody-drug couplings (Enapotamab Vedotin).
Purity:
> 95%
Color and Shape:
Liquid
Ref: TM-T76864
| 1mg | 245.00 € | ||
| 5mg | 642.00 € | ||
| 10mg | 1,007.00 € | ||
| 25mg | 1,466.00 € | ||
| 50mg | 1,995.00 € | ||
| 100mg | 2,682.00 € |
Estimated delivery in United States, on Monday 2 Dec 2024
